1-5 of 5
Madlaina Breuleux
Close
Sort by
Journal Articles

Multiple Myeloma Disease Model to Predict PFS Outcomes across Lines of Therapy, an Analysis Based on Commpass Observational Study

Pascal Chanu, Sandhya Balasubramanian, Divya Samineni, Monica Susilo, Maika Onishi, Felipe A Castro, Madlaina Breuleux, Jin Jin, Chunze Li, René Bruno
Journal: Blood
Blood (2023) 142 (Supplement 1): 4711.
https://doi.org/10.1182/blood-2023-187678
Published: 2023
Journal Articles

Outcomes of Ibrutinib (Ibr) Therapy in Ibr-Naïve Patients (pts) with Chronic Lymphocytic Leukemia (CLL) Progressing after Venetoclax (Ven)

Jennifer R. Brown, MD PhD, Matthew S. Davids, MD, Julie E Chang, MD, Shuo Ma, MD PhD, Juliana M L Biondo, MD, Yong Mun, PhD, Madlaina Breuleux, PhD, William G. Wierda, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4320.
https://doi.org/10.1182/blood-2019-123665
Published: 2019
Journal Articles

Efficacy and Safety of Ibrutinib (IBR) after Venetoclax (VEN) Treatment in IBR-Naïve Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Follow-up of Patients from the MURANO Study

Richard Greil, MD, Graeme Fraser, Brian Leber, MD, Reinhard Marks, Giulia Quaresmini, Jan Moritz Middeke, Gianpietro Semenzato, William Schary, Michelle Boyer, Madlaina Breuleux, PhD DAS, Noelle Crompton, Kathryn Humphrey, Paula Marlton
Journal: Blood
Blood (2018) 132 (Supplement 1): 5548.
https://doi.org/10.1182/blood-2018-99-118148
Published: 2018
Journal Articles

Minimal Residual Disease Status with Venetoclax Monotherapy Is Associated with Progression-Free Survival in Chronic Lymphocytic Leukemia

William G. Wierda, MD PhD, Andrew W. Roberts, MBBS, PhD, Paolo Ghia, MD PhD, Jennifer R. Brown, MD PhD, Stephan Stilgenbauer, Florence Cymbalista, MD, Nicole Lamanna, MD, John F. Seymour, MBBS, PhD, Sebastian Böttcher, MD, Madlaina Breuleux, PhD DAS, Brenda Chyla, Lang Zhou, PhD, Jacqueline Nielsen, PhD, Su Young Kim, MD PhD, Jalaja Potluri, MD, Johnathan C. Maher, PhD, Peter Hillmen, MB ChB, PhD FRCP, FRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 3134.
https://doi.org/10.1182/blood-2018-99-110183
Published: 2018
Journal Articles

Venetoclax Improves Quality of Life for Patients with Elapsed/Refractory Chronic Lymphocytic Leukemia

Tara Cochrane, BMBS, FRACP, FRCPA, Tatiana Chagorova, MD, Tadeusz Robak, MD PhD, Su-Peng Yeh, MD, Evgeny Nikitin, MD, Madlaina Breuleux, PhD DAS, Abdullah Masud, PhD, Kavita Sail, PhD, Viktor Komlosi, MD PhD, Mary Ann Anderson, FRACP, FRCPA, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4858.
https://doi.org/10.1182/blood-2018-99-117127
Published: 2018